Cargando…
Meropenem/Vaborbactam: A Review in Complicated Urinary Tract Infections
The global threat of the spread of carbapenem resistance in Enterobacteriaceae has led to the search for new antibacterials. Intravenous meropenem/vaborbactam (Vabomere™) is the first carbapenem/β-lactamase inhibitor combination approved in the USA for use in patients with complicated urinary tract...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132495/ https://www.ncbi.nlm.nih.gov/pubmed/30128699 http://dx.doi.org/10.1007/s40265-018-0966-7 |